The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Azzalure, 125 Speywood units, powder for solution for injection

125 Speywood Powder for solution for injection

Ipsen PharmaPA1613/001/001

Main Information

Trade NameAzzalure, 125 Speywood units, powder for solution for injection
Active SubstancesClostridium botulinum toxin type a haemagglutinin complex
Strength125 Speywood
Dosage FormPowder for solution for injection
Licence HolderIpsen Pharma
Licence NumberPA1613/001/001

Group Information

ATC CodeM03AX Other muscle relaxants, peripherally acting agents
M03AX01 botulinum toxin


Licence Issued26/03/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back